Janux Therapeutics Inc’s recent filing unveils that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Janux Therapeutics Inc’s recently made public that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11
Janux Therapeutics Inc’s recent filing unveils that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Janux Therapeutics Inc’s recent filing unveils that its Chief Business Officer Meyer Andrew Hollman unloaded Company’s shares for reported $0.11